Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2007
06/26/2007US7235395 Lactic acid bacteria as agents for treating and preventing allergy
06/26/2007US7235368 CHP for use as marker for sepsis-type inflammatory diseases
06/26/2007US7235238 Antibodies that bind receptor protein designated 2F1
06/26/2007CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
06/26/2007CA2185037C Iridaceae extract and compositions containing the same
06/21/2007WO2007070872A1 Kinase inhibitors and their uses
06/21/2007WO2007069712A1 Amine compound and use thereof for medical purposes
06/21/2007WO2007069635A1 Vla-4 inhibitory drug
06/21/2007WO2007068736A2 New chemokine antagonists
06/21/2007WO2007068621A1 Novel fused pyrrole derivatives
06/21/2007WO2007068462A2 Mtor inhibitors for the treatment of inflammatory bowel disease
06/21/2007WO2007068382A1 Diaryl urea for treating inflammatory skin. eye and/or ear diseases
06/21/2007WO2007068381A1 Diaryl ureas for treating inflammatory skin, eye and/or ear diseases
06/21/2007WO2007068112A1 Method of treating pain by using opioids and camkiv inhibitors
06/21/2007WO2007045462A3 Novel vanilloid receptor ligands and their use for producing medicaments
06/21/2007WO2007022380A3 Bis-aryl amide compounds and methods of use
06/21/2007WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
06/21/2007US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors
06/21/2007US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate
06/21/2007US20070142465 Macrophage activation inhibitor
06/21/2007US20070142449 Angiogenesis inhibitors
06/21/2007US20070142400 Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/21/2007US20070142375 Pyrrolidine derivatives as factor xa inhibitors
06/21/2007US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
06/21/2007US20070142360 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors
06/21/2007US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity
06/21/2007US20070142344 fluocinonide or fluocinonide acetonide topical with two or more penetration enhancers
06/21/2007US20070142343 Mixture with penetration intensifiers, solvents and emulsifiers
06/21/2007US20070142342 Pharmaceutical compounds
06/21/2007US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ
06/21/2007US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
06/21/2007US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture
06/21/2007US20070142297 New uses for amino acid anticonvulsants
06/21/2007US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade
06/21/2007US20070142291 Methods for treating irritable bowel syndrome
06/21/2007US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2)
06/21/2007US20070141173 Medicament comprising noble metal fine particles
06/21/2007US20070141039 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome
06/21/2007DE60121550T2 Pyrimidin-4-onderivat als LDL-PLA2 Inhibitor Pyrimidin-4-one derivative as LDL-PLA2 inhibitor
06/21/2007CA2637740A1 Fused pyrrole derivatives
06/21/2007CA2633414A1 Diaryl urea for treating inflammatory skin. eye and/or ear diseases
06/21/2007CA2633411A1 Diaryl ureas for treating inflammatory skin, eye and/or ear diseases
06/21/2007CA2633374A1 Amine compound and use thereof for medical purposes
06/21/2007CA2633035A1 Kinase inhibitors and their uses
06/21/2007CA2627939A1 New chemokine antagonists
06/21/2007CA2571886A1 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
06/21/2007CA2531261A1 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
06/20/2007EP1798230A1 Substituted alkylamine derivatives and methods of use
06/20/2007EP1798226A1 Triazole derivative
06/20/2007EP1798223A2 Aryl sulfonamides
06/20/2007EP1797894A2 Vaccine composition
06/20/2007EP1797883A2 Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid
06/20/2007EP1797882A1 Preventive and/or therapeutic medicine for rheumatoid arthritis
06/20/2007EP1797869A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation
06/20/2007EP1797092A1 2-substituted-6-trifluoromethyl purine derivatives with adenosine-a3 antagonistic activity
06/20/2007EP1797074A1 Compounds, compositions containing them, preparation thereof and uses thereof iiii
06/20/2007EP1797070A1 Compounds, compositions containing them, preparations thereof and uses thereof ii
06/20/2007EP1797067A1 New heterocyclic amides
06/20/2007EP1797065A2 Acyclic 1,3-diamines and uses therefor
06/20/2007EP1797044A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
06/20/2007EP1797043A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
06/20/2007EP1663966B1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases
06/20/2007EP1594517B1 Compositions for the treatment of gastrointestinal disorders
06/20/2007EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
06/20/2007EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors
06/20/2007EP1406946B1 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
06/20/2007EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
06/20/2007EP1324760B1 Creatine ester pronutrient compounds and formulations
06/20/2007EP1281083B1 Methods for detecting inflammation and inflammatory conditions
06/20/2007EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use
06/20/2007EP1137439B1 Stabilization of rapamycins or derivatives of rapamycins
06/20/2007EP0789593B1 Yeast-based delivery vehicles
06/20/2007CN1984914A Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as protein kinase ingibitor
06/20/2007CN1984906A Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity
06/20/2007CN1984899A CXCR1 and CXCR2 chemokine antagonists
06/20/2007CN1984667A Medicament for relief of symptoms of joint disorders and inflammatory conditions
06/20/2007CN1982308A Substituted pyrazoles
06/20/2007CN1981886A Nasal delivery devices
06/20/2007CN1981873A Method of manufacturing micro colloidal particle and use of the same
06/20/2007CN1981869A Compound non-carrier antibacterial eye drops containing practofren and its production
06/20/2007CN1981855A Self-emusified composition containing diamond vine extract
06/20/2007CN1981847A Medicinal liquor for treating sprain and contuse
06/20/2007CN1981844A Medicinal liquor for treating wound
06/20/2007CN1981843A Medicinal liquor for treating intumesce
06/20/2007CN1981841A Medicinal liquor for treating felon
06/20/2007CN1981825A Production of hawthorn oleopene preparation and its anti-inflammatory function
06/20/2007CN1981824A Medicinal liquor for treating rheumatosis
06/20/2007CN1981774A Medicinal compositions
06/20/2007CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
06/20/2007CN1981740A Topical composition for delivery of salicylate esters or salicylate salts
06/20/2007CN1981644A Honey ginger beverage and its production
06/20/2007CN1322001C Novel compounds that inhibit factor Xa activity
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/20/2007CN1321689C Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
06/20/2007CN1321666C Combination of medication of containing astragalus root and dragon's blood resin and application
06/20/2007CN1321665C Combination of medication by using beartyberry and dragon's blood resin as combination of activities
06/20/2007CN1321644C Process for making substituted pyrazoles
06/20/2007CN1321639C Arthritis therapeutic drug
06/20/2007CN1321632C Compound saussurea involucrata capsule and its preparation process
06/19/2007US7232909 Pyridine derivatives
1 ... 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 ... 1272